Lubrizol will showcase the benefits of its polymer-based excipients for the solubility, bioavailability and palatability of APIs and nutraceuticals at CPHI Frankfurt (28th- 30th October 2025 at Stand 8.0M71).
Polpharma Biologics has announced that it has signed licensing agreements with MS Pharma for the commercialisation of its biosimilar candidates vedolizumab (PB016), ocrelizumab (PB018) and guselkumab (PB019) in the MENA region.
CN Bio, a provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, has announced the expansion of its Contract Research Services (CRS) with new PhysioMimix computational modelling tools.
TRIMTECH Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, has announced the formation of its Scientific Advisory Board (SAB).
Aptamer, the developer of next-generation synthetic binders for the life sciences industry, has announced that it has signed a new therapeutic development agreement with Invizius.
Qureight has announced the appointment of Craig Rhodes as head of partnerships to lead strategic engagements with pharmaceutical organisations, in line with Qureight’s revenue growth targets.
The Guardtech Group are shortlisted for the Large Pharma Project at the Pharma Industry Awards at the Park Plaza London Riverbank on Wednesday 10th September.
Dr. Subhashis Chakraborty, general manager, head - global product management at ACG Capsules discusses the European Commission's decision on titanium dioxide in pharmaceuticals.
Rotzinger PharmaPack is launching a new filling and capping platform for over-the-counter (OTC) products such as non-aseptic pharmaceuticals as well as solid and liquid products from the cosmetics, personal care, and nutraceutical industries.
